BioSpace News Archive

Triple-S Management Corporation (NYSE: GTS) today announced that its President and Chief Executive Officer Roberto García-Rodríguez, and its EVP and Chief Financial Officer Juan José Román-Jiménez will be presenting at the 2018 Wells Fargo Healthcare Conference on Wednesday, September 5, 2018

DenMat Holdings, LLC today announced that it has entered into an exclusive distribution agreement with Henry Schein UK Holdings Ltd., a subsidiary of Henry Schein, Inc., the world’s leading provider of health care products and services to office based dentists, animal health and medical practitioners.

Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK) (NASDAQ: CHEKW) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company engaged in the development of C-Scan®, an ingestible capsule-based device for preparation-free colorectal cancer screening, today announced it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference

SCYNEXIS, Inc. announced that the Company will participate in the following upcoming investor conferences:

Impel NeuroPharma, a Seattle-based, privately-held biopharmaceutical company focused on therapies for the treatment of central nervous system (CNS) disorders, today announced the first subject has been dosed in a Phase 1, randomized, double-blind, placebo-and-active controlled crossover study of their intranasal olanzapine product

Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing innovative gene therapy products for patients living with serious, life-threatening rare diseases, today announced that it will participate in the following investor conferences in September:

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), is pleased to announce that it has entered into a joint venture agreement with an affiliate of Agroidea SAS (“AGI”), Colombia’s leading agricultural services provider with over 30 years of research, development and production operations.

Ocular Therapeutix , Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Antony Mattessich, President and Chief Executive Officer of Ocular Therapeutix, will present at the H.C. Wainwright 20th Annual Global Investment Conference

Quality Systems, Inc. (NASDAQ:QSII), known to its clients as NextGen Healthcare, announced today that President and Chief Executive Officer, Rusty Frantz, and Chief Financial Officer, Jamie Arnold will present at upcoming investor conferences.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of senior management will present at three investor conferences in Septembe